Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v22-FR Version v10-FR
Language French French
Date Updated 2020-10-15 2020-07-28
Drug Identification Number 00465283 00465283
Brand name HYDREA CAP 500MG HYDREA CAP 500MG
Common or Proper name HYDROXYUREA HYDROXYUREA
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients HYDROXYUREA HYDROXYUREA
Strength(s) 500MG 500MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 1X100 1X100
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-08-01 2020-08-01
Actual start date 2020-08-01 2020-08-01
Estimated end date 2020-10-14 Unknown
Actual end date 2020-10-14
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Increase demand due to competitive shortage -Product on allocation Increase demand due to competitive shortage -Product on allocation
Health Canada comments